Elastin-like Artificial Extracellular Matrix for Pancreatic Islet Cell Transplantation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating diabetes, particularly type 1 diabetes, face challenges in maintaining the viability and survival rate of transplanted pancreatic islet cells due to the destruction of the extracellular matrix during isolation, leading to reduced cell activity and transplantation success rates.
Innovation Solution
A pharmaceutical composition comprising pancreatic islet cells reacted with an elastin-like artificial extracellular matrix (REP) prepared through the fusion of elastin-like polypeptides and ligands, such as VGVPG and RGD, which enhances cell viability and activity, and is administered along with the matrix to mimic the natural extracellular environment, thereby improving transplantation outcomes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If pancreatic islet cells are isolated from the pancreas, then the cells can be transplanted, but the extracellular matrix is destroyed leading to decreased cell activity and reduced survival rate
Solution Approach 1:
The patent applies preliminary action by pre-coating the transplantation site or culture surface with extracellular matrix components before cell transplantation. This prepares a supportive environment in advance that protects cells from matrix destruction during isolation and provides immediate structural support upon transplantation, thereby maintaining cell activity and survival rate while preserving transplantation convenience
Solution Approach 2:
The patent uses extracellular matrix components as an intermediary substance between the pancreatic islet cells and the transplantation environment. This intermediary provides structural support and biochemical signals that protect cells from damage during isolation and facilitate their survival after transplantation, resolving the contradiction between ease of transplantation and cell survival
2Productivity
If pancreatic islet cells are isolated and transplanted, then diabetes treatment is achieved, but cell activity decreases due to extracellular matrix destruction
Solution Approach 1:
The patent applies parameter changes by modifying the physical and biochemical parameters of the transplantation environment through extracellular matrix coating. This includes adjusting surface properties, stiffness, and biochemical composition to match the native pancreatic environment, thereby maintaining cell activity and function while achieving effective diabetes treatment
Solution Approach 2:
The patent uses composite materials combining pancreatic islet cells with extracellular matrix components. This composite structure provides both the functional insulin-secreting cells and the structural/biochemical support needed to maintain cell activity, achieving effective diabetes treatment while preserving cell stability and function
3Device complexity
If transplantation is performed without extracellular matrix support, then the procedure is simpler, but cell fixation rate and survival rate are reduced
Solution Approach 1:
The patent uses disposable extracellular matrix coating materials that are applied to the transplantation site and provide temporary support during the critical initial period after transplantation. These materials are simple to apply and do not require complex permanent structures, maintaining procedural simplicity while significantly improving cell fixation rate and survival rate
Data Source
AI summary
The present invention relates to a pharmaceutical composition for treating diabetes, which includes a pancreatic islet cell and an elastin-like artificial extracellular matrix (REP), and more particularly, to a pharmaceutical composition for treating diabetes, in which pancreatic islet cells are reacted with an elastin-like artificial extracellular matrix and then the resulting cells are administered along with the elastin-like artificial extracellular matrix, thus increasing a survival rate of the transplanted pancreatic islet cells, rapidly restoring a blood glucose level to normal, and maintaining the restored blood glucose level for a long period of time, and, accordingly, diabetes may be more effectively treated.